Venetoclax-Ibrutinib Combinations as First-Line Therapy in Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled Trials with GRADE Approach
Objective: Chronic lymphocytic leukemia (CLL) treatment has shifted from chemoimmunotherapy to targeted agents. Venetoclax and ibrutinib, which act through complementary mechanisms, have shown promise in achieving deep remissions. Their combination may enhance efficacy, but pooled evidence from rand...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Erzincan Binali Yıldırım University School of Medicine
2026-01-01
|
| Seri Bilgileri: | Archives of Basic and Clinical Research |
| Konular: | |
| Online Erişim: | https://abcresearch.net/articles/venetoclax-ibrutinib-combinations-as-first-line-therapy-in-chronic-lymphocytic-leukemia-a-meta-analysis-of-randomized-controlled-trials-with-grade-approach/doi/ABCR.2025.25386 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|